Interview with our new CEO, Bo Rode Hansen, and our comming CSO, Nils Brünner

Our new CEO, Bo Rode Hansen, and our comming CSO, Nils Brünner, has been interviewed by BioStock studio about the changes in the top managemnet in Scandion Oncology.

https://www.biostock.se/2020/09/biostock-studio-scandion-oncology-har-utsett-ny-vd/

Co-funded by the Horizon 2020 programme of the European Union
Co-funded by the COSME programme of the European Union